You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 71 No. 4, April 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Evaluation of Digitalization in Glaucoma

JOSÉ D. PECZON, MD

Arch Ophthalmol. 1964;71(4):500-504.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

According to Simon and Bonting, the cardiac glycoside digoxin administered in its usual dosage to patients having "congenital," "juvenile," and "chronic simple" glaucoma, caused a 45% decrease in aqueous formation, also a fall in intraocular pressure which averaged 14% in "chronic simple" glaucoma.1 When digoxin was administered in combination with acetazolamide, a 65% decrease in aqueous formation was reported, whereas acetazolamide alone caused a 50% decrease. Interference with aqueous formation and lowering of intraocular pressure by digoxin and other cardiac glycosides was thought to be brought about by inhibition of the enzyme Na-K-ATPase in the ciliary processes. According to these observations, the digitalis glycosides with their reasonably low toxicity and easy mode of administration seemed to have promise as an adjunct in the treatment of glaucoma. For further evaluation of practical usefulness and effectiveness, we have accordingly made a trial of digitalization with digoxin and other digitalis glycosides as . . . [Full Text PDF of this Article]


Author Affiliations

Boston

Fellow in the Glaucoma Consultation Service, Massachusetts Eye and Ear Infirmary, Boston 14, Massachusetts.


Footnotes

Submitted for publication Sept 25, 1963.

This work was supported by grants from the Institute of Neurological Diseases and Blindness of the National Institute of Health, United States Public Health Service (Research Grant B-218), and by the Concordia Foundation, under the supervision of W. Morton Grant, MD.

Acknowledgment is due the several residents who participated in obtaining data: D. Weis, C. Beyers, L. Aiello, R. Houle, A. Kroll, D. Miller, R. Robb, T. Aaberg and R. Petersen.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.